These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8820676)

  • 21. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
    Deringer JR; Chen C; Samuel JE; Brown WC
    Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
    PLoS One; 2015; 10(4):e0124664. PubMed ID: 25909586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
    Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti.
    Robinson DM; Hasty SE
    Appl Microbiol; 1974 Apr; 27(4):777-83. PubMed ID: 4825980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
    Fries LF; Waag DM; Williams JC
    Infect Immun; 1993 Apr; 61(4):1251-8. PubMed ID: 8454328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization experiments with recombinant Coxiella burnetii proteins in a murine infection model.
    Tyczka J; Eberling S; Baljer G
    Ann N Y Acad Sci; 2005 Dec; 1063():143-8. PubMed ID: 16481505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of virulence of Coxiella burnetii isolates from bovine milk and from ticks.
    Kocianová E; Kovácová EI; Literák I
    Folia Parasitol (Praha); 2001; 48(3):235-9. PubMed ID: 11699660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Coxiella burnetii by PCR in mice after administration of live M-44 vaccine.
    Mossienko EV; Tokarevich NK; Suvorov AN; Totolian AA
    Folia Microbiol (Praha); 2003; 48(1):103-4. PubMed ID: 12744085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative virulence of diverse Coxiella burnetii strains.
    Long CM; Beare PA; Cockrell DC; Larson CL; Heinzen RA
    Virulence; 2019 Dec; 10(1):133-150. PubMed ID: 30782062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivalent vaccines demonstrate immunogenicity and protect against
    Jan S; Fratzke AP; Felgner J; Hernandez-Davies JE; Liang L; Nakajima R; Jasinskas A; Supnet M; Jain A; Felgner PL; Davies DH; Gregory AE
    Front Immunol; 2023; 14():1192821. PubMed ID: 37533862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.
    Andoh M; Russell-Lodrigue KE; Zhang G; Samuel JE
    Ann N Y Acad Sci; 2005 Dec; 1063():167-70. PubMed ID: 16481509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the efficacy of human Q fever vaccine registered in Australia.
    Chiu CK; Durrheim DN
    N S W Public Health Bull; 2007; 18(7-8):133-6. PubMed ID: 17854543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the efficacy of Q fever vaccines against Coxiella burnetii experimental challenge in pregnant goats.
    Souriau A; Arricau-Bouvery N; Bodier C; Rodolakis A
    Ann N Y Acad Sci; 2003 Jun; 990():521-3. PubMed ID: 12860684
    [No Abstract]   [Full Text] [Related]  

  • 35. Serological response in sheep vaccinated against Coxiella burnetii (Q fever).
    Lang GH; Prescott JF; Williams JC
    Can Vet J; 1994 Jun; 35(6):373-4. PubMed ID: 8069839
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens.
    Sukocheva OA; Marmion BP; Storm PA; Lockhart M; Turra M; Graves S
    QJM; 2010 Nov; 103(11):847-63. PubMed ID: 20639288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL; Elliott JJ; Waag DM; Jaax GP
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of X-irradiation on the immune response of guinea pigs to Q fever vaccine.
    Reynolds SL; Whitford HW; Blemly NR; Staab EV; Craig CP
    Radiat Res; 1968 Oct; 36(1):98-106. PubMed ID: 17387930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.